<DOC>
	<DOCNO>NCT02137096</DOCNO>
	<brief_summary>This pilot study evaluate response rate patient undergoing high dose condition chemotherapy use Etoposide , Carboplatin Ifosfamide follow autologous stem cell transplantation treatment recurrent Nasopharyngeal Cancer ( NPC ) child , adolescent , young adult .</brief_summary>
	<brief_title>Autologous Stem Cell Transplantation Patients With Recurrent Nasopharyngeal Carcinoma</brief_title>
	<detailed_description>The use high dose chemotherapy follow autologous peripheral blood stem cell ( PBSC ) transplantation recurrent nasopharyngeal carcinoma show promise compare standard chemotherapy . This study design evaluate response rate toxicity associate undergoing high dose condition Etoposide , Carboplatin Ifosfamide follow autologous stem cell transplantation support treatment recurrent nasopharyngeal carcinoma child , adolescent , young adult .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<criteria>Imaging tissue diagnosis recurrent progressive nasopharyngeal carcinoma Documentation previous treatment include conventional chemotherapy and/or radiation therapy clinically appropriate Ages 2 30 year age Negative serum pregnancy test applicable Calculated creatinine clearance great 60 mL/minute , serum creatinine le 12o micromoles/L , total bilirubin le 2 mg/dL aspartate aminotransferase ( AST ) must less twice upper limit normal Unsuitable candidate autologous transplantation due comorbidities intractable psychosocial issue Pregnancy Breastfeeding woman</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Recurrent nasopharynx carcinoma</keyword>
</DOC>